Sinopharm Tech Holdings Limited (HKG:8156)
Hong Kong
· Delayed Price · Currency is HKD 0.2200
0.00 (0.00%)
Jul 3, 2025, 11:25 AM HKT
Sinopharm Tech Holdings Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| 41.33 | 41.28 | 42.84 | 40.99 | 77.81 | 165.93 | Upgrade
| |
Revenue Growth (YoY) | 0.31% | -3.65% | 4.52% | -47.33% | -53.11% | 281.43% | Upgrade
|
Cost of Revenue | 32.93 | 36.26 | 37.37 | 39.22 | 58.59 | 121.28 | Upgrade
|
Gross Profit | 8.4 | 5.02 | 5.47 | 1.77 | 19.23 | 44.65 | Upgrade
|
Selling, General & Admin | 17.07 | 14.18 | 21.47 | 42.43 | 62.22 | 67.97 | Upgrade
|
Other Operating Expenses | -0.82 | - | - | - | - | - | Upgrade
|
Operating Expenses | 17.49 | 15.42 | 20.59 | 76.39 | 75.08 | 70.6 | Upgrade
|
Operating Income | -9.09 | -10.4 | -15.12 | -74.62 | -55.85 | -25.95 | Upgrade
|
Interest Expense | -25.43 | -23.93 | -8.57 | -16.41 | -14.55 | -18.15 | Upgrade
|
Interest & Investment Income | 0.07 | 0.08 | 0 | 0 | 0 | 0 | Upgrade
|
Earnings From Equity Investments | - | - | 0.19 | -0.15 | 3.59 | 0.56 | Upgrade
|
Currency Exchange Gain (Loss) | - | - | - | - | - | 0.47 | Upgrade
|
Other Non Operating Income (Expenses) | 0.26 | 0.26 | 31.19 | 3.84 | 4.6 | 8.03 | Upgrade
|
EBT Excluding Unusual Items | -34.19 | -33.99 | 7.68 | -87.34 | -62.21 | -35.04 | Upgrade
|
Impairment of Goodwill | - | - | - | -12.31 | -33.83 | -131.42 | Upgrade
|
Gain (Loss) on Sale of Investments | -2.73 | -2.73 | -18.53 | -21.89 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 14.53 | 16.56 | - | 8.69 | 0.37 | - | Upgrade
|
Asset Writedown | - | - | - | -8.13 | -4.6 | -1.64 | Upgrade
|
Other Unusual Items | -0.16 | -0.16 | - | 26.82 | -10.8 | 2.72 | Upgrade
|
Pretax Income | -22.55 | -20.33 | -10.85 | -94.16 | -111.06 | -165.38 | Upgrade
|
Income Tax Expense | 0.07 | 0.08 | -1.31 | -0.39 | -0.56 | -1.39 | Upgrade
|
Earnings From Continuing Operations | -22.62 | -20.42 | -9.54 | -93.77 | -110.51 | -163.99 | Upgrade
|
Earnings From Discontinued Operations | 0.39 | 0.39 | -0.56 | - | - | - | Upgrade
|
Net Income to Company | -22.24 | -20.03 | -10.1 | -93.77 | -110.51 | -163.99 | Upgrade
|
Minority Interest in Earnings | -0.1 | 0.33 | -0.54 | 5.77 | 4.17 | 2.92 | Upgrade
|
Net Income | -22.34 | -19.7 | -10.64 | -88 | -106.34 | -161.08 | Upgrade
|
Net Income to Common | -23.29 | -19.7 | -10.64 | -88 | -106.34 | -161.08 | Upgrade
|
Shares Outstanding (Basic) | 241 | 184 | 183 | 180 | 172 | 165 | Upgrade
|
Shares Outstanding (Diluted) | 241 | 184 | 183 | 180 | 172 | 165 | Upgrade
|
Shares Change (YoY) | 31.48% | 0.45% | 1.66% | 4.59% | 4.39% | 19.14% | Upgrade
|
EPS (Basic) | -0.10 | -0.11 | -0.06 | -0.49 | -0.62 | -0.98 | Upgrade
|
EPS (Diluted) | -0.10 | -0.11 | -0.06 | -0.49 | -0.62 | -0.98 | Upgrade
|
Free Cash Flow | -12.05 | -12.58 | 4.73 | -36.89 | -16.33 | 0.55 | Upgrade
|
Free Cash Flow Per Share | -0.05 | -0.07 | 0.03 | -0.20 | -0.10 | 0.00 | Upgrade
|
Gross Margin | 20.32% | 12.16% | 12.77% | 4.32% | 24.71% | 26.91% | Upgrade
|
Operating Margin | -22.00% | -25.20% | -35.29% | -182.06% | -71.78% | -15.64% | Upgrade
|
Profit Margin | -56.35% | -47.72% | -24.83% | -214.71% | -136.66% | -97.07% | Upgrade
|
Free Cash Flow Margin | -29.14% | -30.48% | 11.05% | -90.00% | -20.98% | 0.33% | Upgrade
|
EBITDA | -8.33 | -9.76 | -13.91 | -73.3 | -50.54 | -18.25 | Upgrade
|
EBITDA Margin | -20.16% | -23.66% | -32.48% | -178.84% | -64.95% | -11.00% | Upgrade
|
D&A For EBITDA | 0.76 | 0.64 | 1.21 | 1.32 | 5.31 | 7.7 | Upgrade
|
EBIT | -9.09 | -10.4 | -15.12 | -74.62 | -55.85 | -25.95 | Upgrade
|
EBIT Margin | -22.00% | -25.20% | -35.29% | -182.06% | -71.78% | -15.64% | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.